EarningsQ2 2023 Earnings Report

Diaceutics (7DC) Q2 2023 Earnings Report

0 Followers

DE:7DC Q2 2023 EPS Results

Actual EPS-€0.02

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.01

Actual Revenue€11.54M

Expected Revenue€11.51M

Beat/MissBeat by +€27.91K

YoY Revenue Growth+31.83%

QuarterQ2 2023

Date09/26/2023

TimeBefore Open

Conference CallTuesday, September 26, 2023

DE:7DC Upcoming Earnings

Diaceutics's next earnings date is estimated for March 15, 2027, based on past reporting schedules.

DE:7DC Q2 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 15, 2027	2026 (Q4)	0.04 / -	0.035	―
Sep 22, 2026	2026 (Q2)	-0.03 / -0.04	-0.033	-17.86% (>-0.01)
May 26, 2026	2025 (Q4)	0.03 / 0.03	0.012	200.00% (+0.02)
Sep 23, 2025	2025 (Q2)	-0.03 / -0.03	-0.036	9.68% (<+0.01)
May 13, 2025	2024 (Q4)	0.02 / 0.01	-0.003	433.33% (+0.02)
Sep 17, 2024	2024 (Q2)	-0.04 / -0.04	-0.021	-72.22% (-0.02)
May 21, 2024	2023 (Q4)	<0.01 / >-0.01	0.021	-116.67% (-0.02)
Sep 26, 2023	2023 (Q2)	- / -0.02	-0.01	-100.00% (-0.01)
Apr 17, 2023	2022 (Q4)	0.02 / 0.02	0.013	63.64% (<+0.01)
Sep 27, 2022	2022 (Q2)	- / -0.01	-0.005	-125.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed